Find Academic Supervisors

Dr. Keith Alexander Sharkey is a Professor in the Department of Physiology and Pharmacology at the Cumming School of Medicine, University of Calgary. He is also a Full Member of both the Hotchkiss Brain Institute and The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases. Dr. Sharkey has been at the University of Calgary since his appointment as Assistant Professor in 1990, dedicating his career to understanding the neural control of the gastrointestinal tract. From 2005-2021, he held the Crohn's and Colitis Canada Chair in Inflammatory Bowel Disease Research, demonstrating his longstanding commitment to advancing knowledge in gastrointestinal sciences. Dr. Sharkey's educational journey began with a BSc (Hons) in Nutrition from the University of London in 1981, followed by a PhD in Physiology from the University of Liverpool in 1985. After completing postdoctoral training in Hungary, the UK, and Canada, he joined the University of Calgary faculty in 1990, where he has remained throughout his distinguished academic career. Dr. Sharkey's research program centers on understanding the physiology and pathophysiology of the neural control of the gastrointestinal tract and brain-gut interactions in health and disease. His laboratory investigates two main areas: the role of the endocannabinoid system in regulating GI motility and intestinal barrier function, and the physiology of the enteric nervous system in controlling motility and barrier function. His work employs state-of-the-art approaches including live cell imaging and molecular genetics. Recent publications show his expanding interest in connections between gut function and neurodegenerative conditions like ALS, with multiple 2024-2025 papers examining sexual dimorphism in disease processes and gut-brain axis mechanisms. Fellow, Royal Society of Canada (2024) Cumming School of Medicine's van de Sande Distinguished Achievement Award for Mentorship (2021) Distinguished Research Award, American Physiological Society (2021) Finkelstein Award for Excellence, Crohn's and Colitis Canada (2016) Fellow, Canadian Academy of Health Sciences (2015) Fellow, Canadian Association of Gastroenterology (2015) Killam Annual Professor Award, University of Calgary (2013) Dr. Sharkey has mentored numerous students throughout his career, as evidenced by his 2021 Mentorship Award. His research is supported by significant funding, including a CIHR Foundation grant exploring how enteric nerves and glia maintain intestinal homeostasis. He has also participated in university strategic initiatives focused on Brain and Mental Health (2015-2021) and Infections, Inflammations and Chronic Diseases (2015-2021), demonstrating his interdisciplinary approach. The Sharkey Lab provides a safe, inclusive, and diverse research environment that encourages open scientific exchange from diverse viewpoints. His laboratory is actively engaged in multiple collaborative projects, including investigations with UBC Okanagan on diet and probiotics targeting the gut-brain metabolic interactome, and with University of Calgary colleagues studying gut microbiota's role in ALS. Dr. Sharkey continues to advance our understanding of neural mechanisms controlling gastrointestinal function with upcoming courses scheduled for Fall 2024 and Winter 2025.

• Enteric nervous system
• Gut-brain axis
• Endocannabinoid system
• +3 more

Alexis Battle is an Associate Professor at Johns Hopkins University with appointments in Biomedical Engineering , Computer Science , and Genetic Medicine (secondary). She directs the Malone Center for Engineering in Healthcare and serves as Deputy Director of the Data Science and AI Institute . Educated at Stanford University (PhD in Computer Science, 2013), Battle transitioned to academia after leadership roles at Google. Research Focus: Battle’s work bridges genomics and machine learning , emphasizing the impact of genetic variation on human health. Her lab develops tools like Watershed to predict functional effects of rare variants, aiming to enhance rare disease diagnosis. Key themes include non-coding DNA analysis , personalized genomics , and systems biology , with applications in cardiovascular disease and neurodegenerative disorders . Publications & Awards: Over 60 peer-reviewed articles in journals like Nature , Science , and Genome Biology , with recent emphasis on single-cell transcriptomics , multiomics integration , and telomere biology . Recipient of the President’s Frontier Award (2022), Microsoft Investigator Fellowship (2019), and Searle Scholar (2016). Scientific Awards: 2022 President’s Frontier Award 2019 Microsoft Investigator Fellowship 2019 Johns Hopkins Discovery Award 2017 Johns Hopkins Catalyst Award 2016 Searle Scholar Advising & Funding: Mentors 11 PhD students, 3 undergraduates, and postdoctoral fellows. Her research is funded by NIH, Searle Scholars, and institutional grants. The Battle Lab collaborates on projects like the GTEx Consortium , focusing on gene regulation and clinical genomics .

• Genomics
• Machine Learning
• Computational Biology
• +3 more

Erik Willcutt is a Professor in the Department of Psychology and Neuroscience at the University of Colorado Boulder. His research focuses on the genetic and neurobehavioral underpinnings of ADHD, learning disabilities, and developmental psychopathologies. He holds positions at the Institute for Behavioral Genetics and the Center for Neuroscience. Education: PhD in Psychology from the University of Denver (1998). Research Interests: Etiology and assessment of ADHD, reading disabilities, and developmental psychopathologies. His work integrates behavioral genetics, neuroimaging, and longitudinal twin studies to understand cognitive and psychiatric disorders. Key topics include neuroanatomical correlates of ADHD, genetic influences on dyslexia, and comorbidity between learning disabilities and psychiatric conditions. Publications highlight advanced methods like genome-wide association studies (GWAS) and phenotype harmonization (e.g., Rosetta method). His work bridges molecular genetics with clinical psychology, emphasizing translational research. Lab/Affiliations: Active in the Institute for Behavioral Genetics and collaborates with interdisciplinary teams studying neurodevelopmental disorders. Office located at Muenzinger D451B.

• Behavioral Genetics
• Psychiatric Genetics
• ADHD Etiology
• +3 more

Professor Victor Fung is a leading academic in neurology and motor control at the Sydney Medical School , University of Sydney. He serves as Director of the Movement Disorders Unit at Westmead Hospital and holds prominent roles in the International Parkinson and Movement Disorder Society (President) and the Asia Pacific Affairs Committee of the Australian and New Zealand Association of Neurologists. His research focuses on Parkinson's disease , dystonia , tremor , and movement disorder genetics , with over 250 peer-reviewed publications and an h-index of 61. His work spans Clinical trials for Parkinson's treatments (e.g., foslevodopa/foscarbidopa infusion, incobotulinumtoxinA) Genetic studies on dystonia and Parkinsonism Neurophysiological assessments of tremor and balance Development of screening tools for dystonia and Parkinson's complications Key article trends highlight genetic diversity in dystonia, neuroinflammatory mechanisms in tremor, and behavioral neurology in Parkinson's disease. He contributes to editorial boards of npj Parkinson's Disease , Journal of Clinical Movement Disorders , and Faculty Opinions . While no explicit student lists are provided, his collaborations span global institutions. His clinical work at Westmead Hospital addresses device-assisted therapies and complex movement disorders.

• Neurology
• Movement Disorders
• Parkinson's Disease
• +6 more

Brian Greenfield, MD, FRCPC, ABPN is an Associate Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC) and affiliated with the Brain Repair and Integrative Neuroscience (BRaIN) Program. He is a professor at McGill University and focuses on childhood suicide research through genetic predisposition, disease pathways, treatments, and predictive testing. His work intersects with mental health, borderline personality disorder (BPD), and externalizing disorders in youth. Email: brian.greenfield@muhc.mcgill.ca Dr. Greenfield's research explores the genetic and clinical dimensions of suicide risk in children and adolescents. He investigates biomarkers, predictive algorithms, and treatment models to address mental health crises, particularly in borderline personality disorder and suicidal behaviors. His publications highlight innovative approaches to suicide prevention in youth, including outpatient rapid-response systems, diagnostic tools for BPD, and population-level surveillance algorithms. Research keywords include psychiatry, genetics, health economics, and clinical psychology. As part of the BRaIN Program at RI-MUHC, Dr. Greenfield contributes to translational neuroscience and integrative mental health studies, bridging clinical practice with research to improve outcomes for vulnerable young populations.

• Child Psychiatry
• Psychiatric Genetics
• Mental Health
• +3 more

Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.

• Nuclear Magnetic Resonance (NMR)
• In vivo imaging
• MRI pulse sequence development
• +7 more

Yuguo Chen is a Professor in the Department of Statistics at the University of Illinois at Urbana-Champaign (UIUC), serving as Interim Department Chair and Director of the Illinois Statistics Office. He holds affiliations with the Department of Computer Science, Information Trust Institute, Coordinated Science Lab, and Illinois Informatics Institute. Chen earned his PhD in Statistics from Stanford University (2001) and a B.S. in Mathematics from the University of Science and Technology of China (1997). His research focuses on Monte Carlo methods, network data analysis, state space models, bioinformatics, and Bayesian inference. Key interests include scalable network estimation, community detection, and applications in public health, education, and computational biology. Recent work highlights include advancements in dynamic network modeling, Bayesian latent class models for cognitive diagnosis, and statistical methods for analyzing multi-layer networks. His contributions have been recognized through awards such as the American Statistical Association Fellowship (2018) and the Charles Edison Lectureship (2018). Editorial Roles: Associate Editor of Journal of the American Statistical Association , Journal of Computational and Graphical Statistics , and Journal of Algebraic Statistics . Grants & Consulting: Directs the Illinois Statistics Office, providing interdisciplinary research support. Active in collaborative projects involving healthcare, education, and computational infrastructure. Labs & Teams: Leads initiatives at the Coordinated Science Lab and Information Trust Institute, integrating statistical methods with cybersecurity and data-driven decision-making.

• Network Analysis
• Monte Carlo Methods
• Statistical Inference
• +7 more

Bertram Müller-Myhsok is a Research Professor and Research Group Leader at the Max Planck Institute of Psychiatry in Munich, Germany. His research focuses on statistical genetics and transcriptomic data analysis in psychiatric disorders, particularly major depression, PTSD, schizophrenia, and their treatment responses. He integrates machine learning with genetic and clinical data to develop predictive models and stratified treatment approaches. Professional activities include leadership roles in the International Max Planck Research School for Translational Psychiatry and collaborations with institutions like the Institut du Cerveau (Paris) and Bernhard Nocht Institute (Hamburg). His work spans genetic epidemiology, psychiatric genomics, and precision medicine, with over 400 publications in high-impact journals. Key research areas include identifying genetic risk factors for mental disorders, developing polygenic scores, and leveraging omics data to uncover disease mechanisms. He leads projects like Psych-STRATA, a Horizon Europe-funded initiative advancing personalized psychiatry through pharmacogenomics.

• Psychiatric Genetics
• Statistical Genetics
• Transcriptomics
• +3 more

Elin Org is a Professor of Microbiomics at the University of Tartu's Institute of Genomics, where she also serves as Head of the Estonian Genome Centre and Vice Director of the Institute. Her academic career spans over two decades with significant contributions to microbiome and genomic research. Education: PhD in Genetics, University of Tartu (2006) Master's Degree in Molecular Biotechnology and Biomedicine, University of Tartu (2000) Bachelor's Degree, University of Tartu (1997) Classical Singing, Heino Eller Tartu Music School (1996) Professor Org's research primarily focuses on the intricate relationships between host and gut microbiota and their influence on metabolism and common complex diseases. Her work bridges microbiomics, genomics, and complex disease research, with particular emphasis on understanding how gut microbiome composition affects human health. She has pioneered research connecting long-term antibiotic usage with microbiota-dependent effects and has made significant contributions to understanding the role of gut microbiome in conditions such as gestational diabetes, endometriosis, and polycystic ovary syndrome. Her approach integrates advanced computational methods with comprehensive health data to uncover causal relationships in microbiome research. Her recent publications demonstrate a strong trend toward integrating microbiome data with extensive digital health metrics, using machine learning approaches to identify microbial predictors of health outcomes. This work is increasingly focused on translating microbiome research into clinical applications for disease prediction and personalized medicine approaches, particularly in the context of the Estonian Biobank initiative. Major Scientific Recognition: 2025 National Science Award in medical and health sciences 2023 and 2022: Recognized among the world's top 1% most cited researchers by Clarivate Analytics 2020: Member of AcademiaNet, a portal for top female researchers 2017: EMBO Installation grant 2013: Marie Curie International Outgoing Fellowship Professor Org has secured substantial research funding as principal investigator for multiple significant projects, including 'DISCERN - Discovering the causes of three poorly understood cancers in Europe' (€245,466, European Commission) and 'Improving colorectal cancer screening and prediction using microbiome-based biomarkers' (€760,450, Estonian Research Council). She has served as an opponent for numerous PhD theses across European institutions, contributing to the development of emerging researchers in her field. As Head of the Estonian Genome Centre, Professor Org leads a multidisciplinary research team that plays a crucial role in Estonia's transition from biobanking to personalized medicine applications. She is actively involved in international collaborations through COST networks including INFOGUT (focused on in vitro colon models) and ML4Microbiome (statistical and machine learning techniques in human microbiome studies), positioning her at the forefront of global microbiome research initiatives.

• Microbiomics
• Genomics
• Complex Diseases
• +4 more

Dr. Rodolfo J. Flores serves as an Assistant Professor in the Department of Psychology within the College of Liberal Arts at the University of Texas at El Paso (UTEP). His primary research investigates neuromodulator function in the prefrontal cortex, with emphasis on acetylcholine and dynorphin systems during motivational conflict, stress responses, and addiction pathways. He employs advanced optogenetic and biosensor technologies to dissect neural circuitry underlying psychiatric conditions. Dr. Flores earned his Ph.D. in Social Cognitive and Neuroscience from UTEP in 2019, followed by postdoctoral training at the National Institute of Mental Health (NIMH). His work bridges molecular neuroscience with behavioral outcomes, focusing on how stress and substance exposure alter prefrontal cortical function. His research portfolio demonstrates consistent high-impact publication in top neuroscience journals including Nature Neuroscience , Neuron , and Psychoneuroendocrinology . Current work examines opioid neuropeptide dynamics, nicotine-alcohol interactions, and sex-specific hormonal influences on addiction behaviors. Methodologically, he specializes in genetically encoded biosensors and circuit-level manipulations to study threat processing and reward pathways. Dr. Flores teaches graduate and undergraduate courses including PSYC 4341 (Motivation & Emotion), thesis/dissertation supervision (PSYC 5395/6395), and research applications courses. His lab actively trains students through undergraduate research (RSRC 4033) and independent study opportunities (PSYC 4352).

• Behavioral Neuroscience
• Neuromodulators
• Prefrontal Cortex Function
• +3 more

Eric Y. Drogin is an Adjunct Professor and Honorary Professor with dual expertise in clinical psychology and law. He is affiliated with Harvard Medical School, serving on the staff of the Forensic Psychiatry Service at Beth Israel Deaconess Medical Center, and is involved in the Harvard Longwood Psychiatry Residency Training Program. He also teaches at the University of New Hampshire School of Law and lectures internationally at Prifysgol Aberystwyth (formerly University of Wales) in both Psychology and Law. His work integrates mental health and legal systems through research, education, and practice. Education: Doctor of Philosophy (Ph.D.) in Clinical Psychology – Hahnemann University Juris Doctor (J.D.) – Villanova University School of Law Dr. Drogin's research interests center on the intersection of psychology, psychiatry, and law, particularly in forensic assessment, expert testimony, ethics, and mental disability law. His work emphasizes multidisciplinary approaches to legal and clinical challenges, supporting both mental health professionals and attorneys. He regularly presents continuing education seminars across North America, Europe, Asia, and Australia. His scholarly publications span criminal and civil law applications of psychological evidence, guardianship evaluation, forensic assessment standards, and the role of mental health professionals in court. These works reflect a consistent focus on improving legal processes through scientific rigor and ethical practice. Scientific Honors and Professional Recognition: Fellow of the American Psychological Association Fellow of the American Academy of Forensic Psychology Diplomate, American Board of Forensic Psychology Diplomate, American Board of Professional Psychology Life Fellow, American Bar Foundation Dr. Drogin has held leadership roles in major professional organizations, including President of the American Board of Forensic Psychology, Chair of APA committees on Legal Issues and Professional Practice, and Co-Chair of the ABA’s Behavioral & Neuroscience Law Committee. He serves as Editor-in-Chief of The Journal of Psychiatry & Law and has co-authored over 250 publications. While formal student advising is not detailed, his instructional roles in residency programs and trial workshops indicate active mentorship. He is a key figure in advancing forensic psychology through education, policy, and interdisciplinary collaboration.

• Forensic Psychology
• Psychiatry and Law
• Mental Health Law
• +7 more

Sara Hägg is a Senior Lecturer at the Karolinska Institutet , affiliated with the Department of Medical Epidemiology and Biostatistics . She is also a Docent in molecular epidemiology. PhD in Computational Biology (Linköping University, 2009) MSc in Molecular Biology (Stockholm University, 2003) BSc in Computer Science (Stockholm University, 2003) Her research focuses on human biological aging , including measurement of aging markers (telomere length, epigenetic clocks, frailty index), causal pathway analysis, and identification of geroprotectors for age-related diseases. She utilizes longitudinal twin studies (SATSA, GENDER, HARMONY), UK Biobank, and Swedish cohorts with methods like Mendelian randomization and genome-wide analyses . Recent articles demonstrate trends in epidemiological aging research , with emphasis on cardiovascular aging , neurological disease interactions , metabolic profiling , and epigenetic clocks . Her work often involves multivariable modeling and cross-cohort validation . Leadership roles include Director of LifeGene Core Facility (2024-) and Founding Board Member of the Nordic Aging Society (2023-). She serves on expert groups for the Swedish Twin Registry and Strategic Research Area in Epidemiology and Biostatistics .

• Epidemiology
• Gerontology
• Medical Genetics and Genomics
• +3 more

Prof. Casper Hoogenraad is a full professor in Molecular Neuroscience at the Department of Cell Biology, Faculty of Science, Utrecht University. His research focuses on understanding how intracellular protein trafficking underlies neuronal development and function, with particular emphasis on the microtubule cytoskeleton, synaptic cargo trafficking, and synaptic plasticity. He leads an active research group within Utrecht University's Cell Biology department and collaborates extensively with other neuroscience research groups. Education: PhD, Erasmus University Rotterdam (1996-2001) Postdoc, Massachusetts Institute of Technology (2002-2005) Hoogenraad's research spans three main themes: cytoskeleton dynamics during neurodevelopment and synaptic plasticity, motor proteins and adaptors as regulators of synaptic transport, and psychiatric and neurologic disease disorders linked to intracellular transport. His work combines genetics, biochemistry, molecular, and cellular biology methods in in vitro (neuron cultures), ex vivo (brain slices), and in vivo (mice) systems, along with advanced microscopy techniques including immunofluorescent confocal microscopy, high-resolution live cell imaging, and photo-activated localization microscopy (PALM). Analysis of Hoogenraad's recent publications reveals a strong focus on microtubule organization, neuronal polarity, and the molecular mechanisms underlying synaptic function and dysfunction. His work frequently explores how disruptions in intracellular transport contribute to neurological disorders including Alzheimer's disease, schizophrenia, and autism spectrum disorders, with particular attention to the relationship between cytoskeletal organization and cargo transport in neuronal compartments. Scientific Awards and Memberships: ZonMW-VIDI (2004) European Young Investigators (EURYI) award (2005) NWO-ALW VICI (2011) ERC Consolidator grants (2013) FENS-Kavli Network of Excellence (2014) European Molecular Biology Organization (EMBO) (2015) Young Academy of Europe (YAE) (2015) IBRO Kemali Prize (2016) Hoogenraad leads a research group studying neuronal development and function, with a particular focus on how intracellular transport mechanisms contribute to both normal brain function and neurological disorders. His laboratory employs a multidisciplinary approach combining molecular, cellular, and systems neuroscience techniques to investigate the molecular basis of neuronal polarity, synaptic plasticity, and the pathogenesis of neurological disorders. He has secured significant research funding through prestigious grants including ERC Consolidator grants. The Hoogenraad lab operates within the Cell Biology department at Utrecht University, collaborating with other research groups focusing on cellular dynamics, biophysics, and neurobiology. The lab utilizes advanced microscopy techniques including immunofluorescent confocal microscopy, high-resolution live cell imaging (spinning disc microscopy and total internal reflection fluorescence microscopy), and quantitative analysis using advanced high-resolution microscopy (photo-activated localization microscopy). Current lab technicians include Phebe Wulf and Bart de Haan.

• Molecular Neuroscience
• Neuronal Development
• Intracellular Protein Trafficking
• +7 more

Prof. Dr. Dr. Elisabeth Binder is the Director of the Max Planck Institute of Psychiatry and leads the Max Planck Research Group "Genes and Environment" in Munich, Germany. Her research focuses on molecular mechanisms underlying psychiatric disorders, particularly how genetic and environmental factors interact in disease development. Education: Medicine (University of Vienna), Neuroscience (Emory University) Affiliations: Max Planck Institute of Psychiatry, International Max-Planck Research School Translational Psychiatry, Graduate School of Systemic Neuroscience Research Interests: Elisabeth Binder investigates gene-environment interactions in psychiatric disorders, emphasizing early trauma and stress response. Her work employs next-generation sequencing, epigenetic analysis, and induced pluripotent stem cells to identify biological markers for disease prevention and treatment. Scientific Awards: Theodore Reich Young Investigator Award (2010) Max Hamilton Memorial Prize (2012) Eva King-Killam Research Award (2016) Carus Medal (2017) Ron the Kloet Award for Stress Research (2019) Leadership Roles: She is a member of the German National Academy of Sciences (Leopoldina), a Fellow of the American College of Neuropsychopharmacology, and serves on multiple international advisory committees and executive boards in psychiatry and neuroscience.

• Psychiatric Disorders
• Gene-Environment Interactions
• Epigenetics
• +4 more

Alicia Che is an Assistant Professor of Psychiatry at Yale University School of Medicine and serves as Director of Graduate Admissions for the Interdepartmental Neuroscience Program. She joined the Yale Department of Psychiatry in 2021 after completing her postdoctoral fellowship with Dr. Natalia De Marco García at Weill Cornell Medical College and Dr. Gord Fishell at NYU. Her research is conducted through the Che Lab at Yale, where she investigates how early life experiences impact brain circuit assembly and mature function in models of psychiatric illness. Yale School of Medicine, Department of Psychiatry Interdepartmental Neuroscience Program Center for Brain & Mind Health Division of Molecular Psychiatry Wu Tsai Institute Yale Center for the Science of Cannabis and Cannabinoids Dr. Che earned her Ph.D. in Physiology and Neurobiology from the University of Connecticut in 2014, where she worked in the laboratory of Dr. Joseph LoTurco. She received her B.S. with triple majors in Biology, Physics, and Physical Chemistry from Pacific Lutheran University in Washington state in 2009. Her research focuses on understanding developmental trajectories following early life experiences to develop diagnostics and early interventions for psychiatric illnesses. Dr. Che's research examines how sensory inputs, social bonding, stress, and substance exposure impact brain development. She employs a multi-dimensional approach to assess transcriptional, circuit, neuronal activity, and behavioral changes across the entire developmental timeline. Her lab currently focuses on four specific areas: the role of oxytocin in social behavior development, circuit dysfunction in PTSD, early-life cannabinoid exposure effects, and the impact of early life stress on development and adulthood. She utilizes advanced techniques including mouse genetics, slice electrophysiology, and longitudinal in vivo 2-photon imaging on behaving animals. Her most recent publications demonstrate significant contributions to understanding neural circuit development, PTSD mechanisms, and the effects of early life experiences on brain function. Her work spans from molecular neuroscience to behavioral outcomes, with publications in top journals including Nature, Neuron, and Nature Communications. Her research has revealed important insights into how translaminar neuronal activity strengthens cortical columns, how oxytocin facilitates social touch development, and how PTSD affects brain transcriptomics. NARSAD Young Investigator Award (2020) K99/R00 Pathway to Independence Award from NINDS (2019) Dr. Che's work has significant implications for understanding and treating neurodevelopmental disorders, PTSD, and the consequences of early life experiences on mental health. She collaborates extensively with researchers across Yale and beyond, with frequent co-authorship with colleagues including Lin Lin, Alex Kwan, and Christopher Pittenger. Her research program bridges basic neuroscience with clinical applications, aiming to translate findings into potential interventions for psychiatric conditions.

• Neuroscience
• Developmental Neuroscience
• Behavioral Neuroscience
• +5 more